ALK-Abello Competitors and Similar CompaniesClear all
ALK-Abello's competitors and similar companies include Artms, Zetagen Therapeutics, Proteus Digital Health and Proteome Sciences.
 Artms Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope. |  Zetagen Therapeutics Zetagen Therapeutics is a clinical-stage biopharmaceutical company that develops cancer treatments for metastatic bone cancers and osteologic interventions. |  Proteus Digital Health Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics. |  Proteome Sciences Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications | ||
Founding Date | Founding Date 1923 | Founding Date 2013 | Founding Date 2015 | Founding Date 2001 | Founding Date N/A |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Hørsholm, DK HQ | Locations Burnaby, CA HQ | Locations Syracuse, US HQ | Locations Redwood City, US HQ Hayward, US | Locations Addlestone, GB HQ Frankfurt Am Main, DE Cobham, GB |
Employees | Employees 2,736 | Employees 283% decrease | Employees 1011% increase | Employees 632% increase | Employees 363% increase |
Valuation ($) | Valuation ($) 6.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.6 b | Valuation ($) 10.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) kr6.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £3.8m (FY, 2025) |
Cost of goods | Cost of goods kr1.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods £2.9m (FY, 2025) |
Gross profit | Gross profit kr4.5b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit £845k (FY, 2025) |
Net income | Net income kr1.2b (FY, 2025) | Net income N/A | Net income N/A | Net income N/A | Net income (£3.1m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 19m (almost 6 years ago) | Latest funding round N/A | Latest funding round $ 88m (over 7 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 22m | Total funding raised N/A | Total funding raised $ 517m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Artms
HQ
Burnaby, CA
Employees
28↓ 3% decrease
Artms is a company that develops technologies designed to enable the production of diagnostic imaging isotope.
View companyZetagen Therapeutics
HQ
Syracuse, US
Employees
10↑ 11% increase
Zetagen Therapeutics is a clinical-stage biopharmaceutical company that develops cancer treatments for metastatic bone cancers and osteologic interventions.
View companyProteus Digital Health
HQ
Redwood City, US
Employees
63↑ 2% increase
Proteus Digital Health is a company developing digital products that collect and aggregate various behavioral, physiological and therapeutic metrics.
View companyProteome Sciences
HQ
Addlestone, GB
Employees
36↑ 3% increase
Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
View company